drugset / Trial / NCT02510612

Dexmedetomidine Affect Diabetic Patient's Glucose Metabolism

NCT02510612 ↗

Phase 4 Unknown 120 enrolled Shaanxi Provincial People's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Dexmedetomidine's Sedative Effect on Diabetic Patient

Timeline

Start
2015-08
Primary completion
2016-08
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg —